Gainesville, FL (CN) — A family of six is battling breast cancer with two daughters with cystic fibrosis, and their doctors say they can’t afford the expensive surgeries.
The family, who asked not to be identified for fear of jeopardizing their health, received the news this week when the women went to see their gynecologist, who told them to wait until their daughters were 12 and 14 years old before getting the next stage of chemotherapy.
Their mother was told to wait an extra year for surgery, and her daughter is now 14 months along.
The gynecological department at Loyola University Medical Center in Chicago, which specializes in breast cancer care, did not respond to an interview request Monday.
It is the third year the family has received this kind of message.
But Dr. David E. Miller, the chief of gynecologic oncology at LUC, said it’s too early to tell whether the girls’ cancers have returned to normal after the chemotherapy.
“We are still treating them with a combination of chemo and radiotherapy, which we’re trying to minimize their impact on their health,” he said.
“This is not a cure for the cancer, but we can minimize the impact of the cancer on their lives.”
A gynecoplastist at LUCKY LAND, a clinic that specializes in oncological care in Southern California, said the cancer has returned.
“The most important thing is that they’re on the treatment and they’re doing well,” said Dr. Michael Schulz.
He said the girls have had the best treatment, but it’s premature to tell them what they should do.
“They’re going to be their own doctors for a long time,” Schulz said.
He called the message “truly shocking.”
Dr. Robert T. Miller told the family that he was concerned about their health.
“I’m concerned about the quality of care and the quality-of-life of these kids, but I also think about the patients,” he told them.
Miller is president of the Gainesville Women’s Health Society, which represents about 250 gynecotherapists and obstetricians in the county.
The group is holding a meeting Monday to discuss the new message.
The women are in their late 30s, and one is pregnant with their second child.
Their father is a cancer survivor.
Their mothers, who have been cancer-free since childhood, are on the cancer treatment.
The men have been on the chemotherapy and radiation for two years.
The girls’ mothers have not had a tumor removed, so they are not eligible for the treatment.
Dr. Miller said that he is concerned that the daughters’ cancers will return if they get the next dose of chemoprevention.
“It’s important for them to understand the fact that if they do have a relapse of cancer, then it will not be the same,” he added.
“That’s one of the things we have to keep in mind: the next time that they get chemotherapy, it may be much worse.”
He said that the girls are very busy with the new life they are creating together.
“These girls have very much enjoyed the life they’ve created together, and I think that’s one reason why we want to help them understand what we’ve done to get them through this journey, and that’s why we’ve decided to go into this new phase of treatment,” he explained.
“But it is going to take a little bit of time to get there.”
In addition to chemotherapy, the family will be receiving radiation treatments.
The radiotherapy is being done in a private clinic, but they will not have access to any of the other treatments available to cancer patients.
Dr.-elect Dr. Jeffrey K. Schulz, an obstetrician and gynecographer at LUBB, who has been working in the gyneciatrics division at LUNY, has treated many women with cyst-related breast cancers.
He’s not surprised by the message from the gynecomastia clinic.
“As a gynecocompetent, you just know it’s going to cause some complications,” he pointed out.
It’s our cancer.’ “
So the message to the parents is, ‘It’s not your baby’s cancer.
He explained that the gynescomastic cancer is much more advanced than cystic cystic breast cancer, and the treatment is more invasive and more costly. “
Dr. Miller noted that the women are not in their 40s.
He explained that the gynescomastic cancer is much more advanced than cystic cystic breast cancer, and the treatment is more invasive and more costly.
He also noted that it’s the second time that a gyneCOMASTIC cancer has been treated at LURY L.E. “What we’re hoping is that this is a signal that we have been sending out, that we know the cancer is